Ferritin Testing Market Size, Share, Industry, Forecast and outlook (2024-2031)

Ferritin Testing Market is Segmented By Product Type (Instrument, Reagent, Kits), By Application( Anemia, Hemochromatosis, Lead Poisoning, Other), By End-User(Hospitals, Diagnostic Laboratories, Clinics, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023- 2030.

Ferritin Testing Market Overview

The Ferritin Testing Market size is estimated to reach at a high CAGR 6.3% during the forecast period 2023- 2030. 179 pages report analyses the Ferritin Testing market shares, recent trends, competitive intelligence and future market outlook. Ferritin Testing usage in diagnosis of  iron deficiency is on the rise. Competitive rivalry intensifies with bioMérieux SA, Seksui Diagnostic, Orgentec Diagnostika, Thermofisher Scientific and others operating in the market.

A ferritin test measures the amount of ferritin in the blood. Ferritin is a blood protein that contains iron. If a ferritin test reveals that blood ferritin level is lower than normal, it indicates the body's iron stores are low and have iron deficiency. As a result, the patient could be anemic. If a ferritin test shows higher than normal levels, it could indicate that have a condition that causes the body to store too much iron. It could also point to liver disease, rheumatoid arthritis, and other inflammatory conditions.  

Ferritin Testing Market Scope

To Get a Free Sample Click here

Market Dynamics

The global ferritin testing market growth is driven by the increasing prevalence of anemia, ageing population, and malnutrition is driving the demand for ferritin testing globally to measure the level of iron in the blood. 

The growing burden of iron deficiency disorders drives ferritin testing market growth 

Iron is an essential dietary mineral required for various functions, including the transport of oxygen in the blood. Iron is also vital for brain development. Infants, children, and teenagers undergo rapid growth changes, which increase their need for iron. Iron is the most common nutritional deficiency among infants, children, and pregnant women and is associated with long-term detrimental effects on neurodevelopment. As per the World Health Organization (WHO), nearly 42% of children less than five years of age and 40% of pregnant women worldwide are anemic. Poor nutritional habits increase blood loss during menstruation and increased blood-supply demands during pregnancy contribute to the increased prevalence of anemia in women. Apart from this, hemoglobinopathies and infectious diseases such as malaria, tuberculosis, and parasitic infections cause anemia. To reduce the burden of anemia in infants, many government organizations have recommended screening for iron deficiency, which is driving the ferritin market.

For instance, the American Academy of Pediatrics has recommended universal screening for iron deficiency at 12 months. The WHO also suggests an assessment of ferritin and soluble transferrin receptor levels during pregnancy and early childhood. Measurement of ferritin aids in the diagnosis of iron metabolism. Furthermore, technological developments are expected to propel the growth of the market. For instance, in 2019, Eurolyser Diagnostica GmbH added a new feature to its product Cube, which is used for testing iron deficiency. Therefore, the increasing prevalence of iron deficiency and government regulations to reduce anemia is expected to fuel the growth of the ferritin testing market. 

The presence of an alternative transferrin saturation test is likely to hamper the market growth  

However, serum ferritin level indicates total iron stores, while transferrin saturation value reflects iron transportation, which decreases before anemia develops. Moreover, government initiatives to reduce anemia worldwide is expected to hamper the market growth during the forecast period. However, the availability of advanced technologies is restricting the market growth.

Industry Analysis  

COVID-19 Impact Analysis

Ferritin is a key mediator of immune dysregulation, especially under extreme hyperferritinemia, via direct immune-suppressive and pro-inflammatory effects, contributing to the cytokine storm. Many individuals with diabetes exhibit elevated serum ferritin levels, and it is known that they face a higher probability to experience serious complications from COVID-19. In one study with 20 COVID-19 patients, it was found that individuals with severe and very severe COVID-19 exhibited increased serum ferritin levels, being serum ferritin in the very severe COVID-19 group significantly higher than in the severe COVID-19 group. In agreement with this, another study revealed that in patients who died by COVID-19, ferritin levels were high upon hospital admission and throughout the hospital stay.   

Segment Analysis

Anemia segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)       

The anemia segment held the largest share of the market in 2020 and is also anticipated to register the highest CAGR during the forecast period. The growth of the anemia segment is attributed to the lack of nutritional diet, changing dietary habits, and lack of awareness regarding iron deficiency worldwide. As per WHO, anemia affects 1.62 billion people, which corresponds to 24.8% of the population. The highest prevalence is in preschool-age children, and the lowest prevalence is in men. However, the population group with the greatest number of individuals affected is non-pregnant women (468.4 million). Anemia is the most common blood condition in the U.S. It affects almost 6% of the population. Women, young children, and people with long-term diseases are more likely to have anemia. Anemia can make feel tired, cold, dizzy, and irritable. Pearson may be short of breath or have a headache. Iron deprivation from erythroblasts and other tissues occurs when total body stores of iron are low or when inflammation causes withholding of iron from the plasma, particularly through the action of hepcidin, the main regulator of systemic iron homeostasis. 

Geographical Analysis

North America region holds the largest market share of the global ferritin testing market 

North America is expected to hold a major market share in the global ferritin testing market due to the increasing ageing population and its associated iron deficiency disorders. The older population is likely to suffer from iron deficiency disorders such as anemia. According to the Population Reference Bureau, in 2018, approximately 52 million people were recorded to be with aged 65 years and above. 

According to the study Mechanisms of Aging Development, in 2018, around 10% of pregnant women were diagnosed with iron deficiency and around 1% of men had low levels of iron in the United States. Thus, increasing prevalence is expected to boost the demand for ferritin testing. 

Competitive Landscape 

The ferritin testing market is moderately competitive with the presence of local as well as companies. Some of the key players which are contributing to the growth of the market include bioMérieux SA, Seksui Diagnostic, Orgentec Diagnostika, Thermofisher Scientific, Cortez Diagnostica Inc., Eurolyser Diagnostica GmbH, Pointe Scientific Inc., Aviva System Biology Corporation, Abnova Corporation, and Monobind Inc. among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the ferritin testing market globally. 

Thermo Fisher Scientific 

Overview: 

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.   

Product Portfolio:

Ferritin Human ELISA Kit:  The Human Ferritin ELISA quantitates Hu Ferritin in human serum, plasma, or cell culture medium. The assay will recognize both natural and recombinant Hu Ferritin. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody.